Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.

Jeon HJ, Choe AR, Kim SE

Open source

DOI
10.2147/ijn.s620995
Published
2026
Container
International journal of nanomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijn.s620995,
  title = {Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.},
  author = {Jeon HJ and Choe AR and Kim SE},
  year = {2026},
  journal = {International journal of nanomedicine},
  doi = {10.2147/ijn.s620995},
  url = {https://doi.org/10.2147/ijn.s620995}
}

RIS

TY  - JOUR
TI  - Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.
AU  - Jeon HJ
AU  - Choe AR
AU  - Kim SE
PY  - 2026
JO  - International journal of nanomedicine
DO  - 10.2147/ijn.s620995
UR  - https://doi.org/10.2147/ijn.s620995
ER  - 

APA

HJ, J., AR, C., & SE, K. (2026). Probiotic-Derived Extracellular Vesicles as Potential Nano-Immunotherapeutic Platforms in IBD: A Clinician's Perspective.. International journal of nanomedicine. https://doi.org/10.2147/ijn.s620995

Source records